Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,903,812
+$1,214,183 QoQ
Shares Held
546,930
-2.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#253
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. JNJ ranks #1 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,903,812 | 546,930 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $137,689,629 | 563,286 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $116,389,714 | 562,405 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $112,560,879 | 607,059 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $95,009,889 | 621,996 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $104,695,787 | 631,306 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $90,648,972 | 626,808 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $86,673,739 | 534,825 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $79,827,184 | 546,163 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $90,600,158 | 572,730 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $90,098,070 | 574,825 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $91,746,095 | 589,060 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $99,953,390 | 603,875 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $95,769,540 | 617,868 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $110,940,969 | 628,027 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $103,482,025 | 633,460 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $113,127,655 | 637,303 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $109,785,122 | 619,450 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $106,555,396 | 622,876 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $100,751,936 | 623,851 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $106,324,019 | 645,405 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $106,274,790 | 646,637 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $103,116,319 | 655,206 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $98,051,623 | 658,595 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $93,810,616 | 667,074 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $86,767,802 | 661,693 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||